Last Updated: May 25, 2026

MYLAN TECHNOLOGIES Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MYLAN TECHNOLOGIES

MYLAN TECHNOLOGIES has twelve approved drugs.

Summary for MYLAN TECHNOLOGIES

US Patents:	0
Tradenames:	15
Ingredients:	8
NDAs:	12
PTAB Cases with MYLAN TECHNOLOGIES as petitioner:	See PTAB cases with MYLAN TECHNOLOGIES as petitioner

Drugs and US Patents for MYLAN TECHNOLOGIES

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Technologies	FENTANYL-12	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	076258-005	Jan 23, 2007	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Technologies	ESTRADIOL	estradiol	FILM, EXTENDED RELEASE;TRANSDERMAL	075182-006	Feb 24, 2000	AB2	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Technologies	RIVASTIGMINE	rivastigmine	FILM, EXTENDED RELEASE;TRANSDERMAL	205622-002	Jun 20, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Technologies	CLONIDINE	clonidine	SYSTEM;TRANSDERMAL	076166-003	Jul 16, 2010	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Technologies	SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	203753-001	Jun 19, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mylan Technologies	RIVASTIGMINE	rivastigmine	FILM, EXTENDED RELEASE;TRANSDERMAL	205622-001	Jun 20, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.